Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Treatment Of Experimental CIDP Using Lentivirus Transduced Dendritic Cells Expressing VIP
Neuromuscular and Clinical Neurophysiology (EMG)
(-)
005
Authors/Disclosures
Mehmet E. Yalvac, PhD (The Ohio State Univ. Dept. of Neurology)
PRESENTER
Dr. Yalvac has nothing to disclose.
William D. Arnold, MD Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for La Hoffmann Roche. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadent Therapeutics . Dr. Arnold has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Arnold has received research support from NIH. The institution of Dr. Arnold has received research support from NMD Pharma. The institution of Dr. Arnold has received research support from Gilead Sciences. The institution of Dr. Arnold has received research support from CureSMA. Dr. Arnold has received intellectual property interests from a discovery or technology relating to health care.
No disclosure on file
No disclosure on file
K. Reed Clark, PhD No disclosure on file
Eroboghene E. Ubogu, MD, MBBS (The University of Alabama At Birmingham) No disclosure on file
Jerry R. Mendell, MD, FAAN (The Research Institute at Nationwide Children's Hospital) Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta Therapeutics . The institution of Dr. Mendell has received research support from Sarepta.
Zarife Sahenk, MD, PhD, FAAN (The Research Institute at Nationwide Childrens.org) Dr. Sahenk has nothing to disclose.
Christopher Scherfler, MD (PET Neurology) No disclosure on file